Nephrolithiasis
Authors: Christine Laine
Journal: Annals of Internal Medicine (2009)

In the Clinic4 August 2009NephrolithiasisChristine Laine, MD, MPH, Sankey Williams, MD, and David S. Goldfarb, MDChristine Laine, MD, MPHSearch for more papers by this author, Sankey Williams, MDSearch for more papers by this author, and David S. Goldfarb, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-151-3-200908040-01002 SectionsSupplemental MaterialAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail As many as 13% of men and 7% of women in the United States will have at least 1 kidney stone. Recent evidence suggests that the prevalence of kidney stones is increasing (1), perhaps because they are associated with hypertension, diabetes, obesity, chronic kidney disease, and the metabolic syndrome (2, 3). Between 1994 and 2000, outpatient visits for stone disease increased by 40%, and office visits increased by 43%. Stones recur frequently, with 50% of patients having a second stone within 5 years of the first one, and 80% having a second stone within 20 years. Kidney stones are expensive ...References1. Stamatelou KK, Francis ME, Jones CA, et al. Time trends in reported prevalence of kidney stones in the United States: 1976-1994. Kidney Int. 2003;63:1817-23. [PMID: 12675858] Google Scholar2. Taylor EN, Stampfer MJ, Curhan GC. Obesity, weight gain, and the risk of kidney stones. JAMA. 2005;293:455-62. [PMID: 15671430] Google Scholar3. Daudon M, Traxer O, Conort P, et al. Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol. 2006;17:2026-33. [PMID: 16775030] Google Scholar4. Saigal CS, Joyce G, Timilsina AR; Urologic Diseases in America Project. Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int. 2005;68:1808-14. [PMID: 16164658] Google Scholar5. Goldfarb DS, Fischer ME, Keich Y, et al. A twin study of genetic and dietary influences on nephrolithiasis: a report from the Vietnam Era Twin (VET) Registry. Kidney Int. 2005;67:1053-61. [PMID: 15698445] Google Scholar6. Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol. 2008;19:1197-203. [PMID: 18322162] Google Scholar7. Lieske JC, Kumar R, Collazo-Clavell ML. Nephrolithiasis after bariatric surgery for obesity. Semin Nephrol. 2008;28:163-73. [PMID: 18359397] Google Scholar8. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155:839-43. [PMID: 8583588] Google Scholar9. Lauderdale DS, Thisted RA, Wen M, et al. Bone mineral density and fracture among prevalent kidney stone cases in the Third National Health and Nutrition Examination Survey. J Bone Miner Res. 2001;16:1893-8. [PMID: 11585355] Google Scholar10. Eisner BH, Reese A, Sheth S, et al. Ureteral stone location at emergency room presentation with colic. J Urol. 2009;182:165-8. [PMID: 19450856] Google Scholar11. Longo J, Akbar SA, Schaff T, et al. A prospective comparative study of non-contrast helical computed tomography and intravenous urogram for the assessment of renal colic. Emerg Radiol. 2001;8:285-92. Google Scholar12. Ferrandino MN, Bagrodia A, Pierre SA, et al. Radiation exposure in the acute and short-term management of urolithiasis at 2 academic centers. J Urol. 2009;181:668-72; discussion 673. [PMID: 19100573] Google Scholar13. Poletti PA, Platon A, Rutschmann OT, et al. Low-dose versus standard-dose CT protocol in patients with clinically suspected renal colic. AJR Am J Roentgenol. 2007;188:927-33. [PMID: 17377025] Google Scholar14. Zagoria RJ, Dixon RL. Radiology of urolithiasis: implications of radiation exposure and new imaging modalities. Adv Chronic Kidney Dis. 2009;16:48-51. [PMID: 19095205] Google Scholar15. National Institutes of Health Consensus Development Conference on Prevention and Treatment of Kidney Stones. Bethesda, Maryland, March 28-30, 1988. J Urol. 1989;141:705-808. [PMID: 2645426] Google Scholar16. Tiselius HG, Ackermann D, Alken P, et al; Working Party on Lithiasis, European Association of Urology. Guidelines on urolithiasis. Eur Urol. 2001;40:362-71. [PMID: 11713390] Google Scholar17. Parks JH, Asplin JR, Coe FL. Patient adherence to long-term medical treatment of kidney stones. J Urol. 2001;166:2057-60. [PMID: 11696706] Google Scholar18. Asplin J, Parks J, Lingeman J, et al. Supersaturation and stone composition in a network of dispersed treatment sites. J Urol. 1998;159:1821-5. [PMID: 9598467] Google Scholar19. Larkin GL, Peacock WF 4th, Pearl SM, et al. Efficacy of ketorolac tromethamine versus meperidine in the ED treatment of acute renal colic. Am J Emerg Med. 1999;17:6-10. [PMID: 9928687] Google Scholar20. Safdar B, Degutis LC, Landry K, et al. Intravenous morphine plus ketorolac is superior to either drug alone for treatment of acute renal colic. Ann Emerg Med. 2006;48:173-81, 181.e1. [PMID: 16953530] Google Scholar21. Segura JW, Preminger GM, Assimos DG, et al. Ureteral Stones Clinical Guidelines Panel summary report on the management of ureteral calculi. The American Urological Association. J Urol. 1997;158:1915-21. [PMID: 9334635] Google Scholar22. Preminger GM, Tiselius HG, Assimos DG, et al; EAU/AUA Nephrolithiasis Guideline Panel. 2007 guideline for the management of ureteral calculi. J Urol. 2007;178:2418-34. [PMID: 17993340] Google Scholar23. Curhan GC, Willett WC, Rimm EB, et al. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328:833-8. [PMID: 8441427] Google Scholar24. Curhan GC. Dietary calcium, dietary protein, and kidney stone formation. Miner Electrolyte Metab. 1997;23:261-4. [PMID: 9387129] Google Scholar25. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346:77-84. [PMID: 11784873] Google Scholar26. Pearle MS, Roehrborn CG, Pak CY. Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol. 1999;13:679-85. [PMID: 10608521] Google Scholar27. Ettinger B, Citron JT, Livermore B, et al. Chlorthalidone reduces calcium oxalate calculous recurrence but magnesium hydroxide does not. J Urol. 1988;139:679-84. [PMID: 3280829] Google Scholar28. Adams JS, Song CF, Kantorovich V. Rapid recovery of bone mass in hypercalciuric, osteoporotic men treated with hydrochlorothiazide. Ann Intern Med. 1999;130:658-60. [PMID: 10215562] Google Scholar29. Barcelo P, Wuhl O, Servitge E, et al. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol. 1993;150:1761-4. [PMID: 8230497] Google Scholar30. Parks JH, Coe FL, Evan AP, et al. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009;24:130-6. [PMID: 18662977] Google Scholar31. Seltzer MA, Low RK, McDonald M, et al. Dietary manipulation with lemonade to treat hypocitraturic calcium nephrolithiasis. J Urol. 1996;156:907-9. [PMID: 8709360] Google Scholar32. Odvina CV. Comparative value of orange juice versus lemonade in reducing stone-forming risk. Clin J Am Soc Nephrol. 2006;1:1269-74. [PMID: 17699358] Google Scholar33. Kang DE, Sur RL, Haleblian GE, et al. Long-term lemonade based dietary manipulation in patients with hypocitraturic nephrolithiasis. J Urol. 2007;177:1358-62; discussion 1362; quiz 1591. [PMID: 17382731] Google Scholar34. Ettinger B, Pak CY, Citron JT, et al. Potassium-magnesium citrate is an effective prophylaxis against recurrent calcium oxalate nephrolithiasis. J Urol. 1997;158:2069-73. [PMID: 9366314] Google Scholar35. Massey L. Magnesium therapy for nephrolithiasis. Magnes Res. 2005;18:123-6. [PMID: 16100850] Google Scholar36. Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med. 1986;315:1386-9. [PMID: 3534570] Google Scholar37. Rodman JS. Intermittent versus continuous alkaline therapy for uric acid stones and ureteral stones of uncertain composition. Urology. 2002;60:378-82. [PMID: 12350465] Google Scholar38. Maalouf NM, Cameron MA, Moe OW, et al. Novel insights into the pathogenesis of uric acid nephrolithiasis. Curr Opin Nephrol Hypertens. 2004;13:181-9. [PMID: 15202612] Google Scholar39. Maalouf NM, Cameron MA, Moe OW, et al. Low urine pH: a novel feature of the metabolic syndrome. Clin J Am Soc Nephrol. 2007;2:883-8. [PMID: 17702734] Google Scholar40. Goldfarb DS, Coe FL, Asplin JR. Urinary cystine excretion and capacity in patients with cystinuria. Kidney Int. 2006;69:1041-7. [PMID: 16501494] Google Scholar41. Mattoo A, Goldfarb DS. Cystinuria. Semin Nephrol. 2008;28:181-91. [PMID: 18359399] Google Scholar42. Griffith DP, Gleeson MJ, Lee H, et al. Randomized, double-blind trial of Lithostat (acetohydroxamic acid) in the palliative treatment of infection-induced urinary calculi. Eur Urol. 1991;20:243-7. [PMID: 1726639] Google Scholar43. Asplin JR, Bauer KA, Kinder J, et al. Bone mineral density and urine calcium excretion among subjects with and without nephrolithiasis. Kidney Int. 2003;63:662-9. [PMID: 12631132] Google Scholar44. Rule AD, Bergstralh EJ, Melton LJ 3rd, et al. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4:804-11. [PMID: 19339425] Google Scholar45. Glowacki LS, Beecroft ML, Cook RJ, et al. The natural history of asymptomatic urolithiasis. J Urol. 1992;147:319-21. [PMID: 1732583] Google Scholar46. Cupisti A, Vagelli G, Morelli E, et al. Outcome of asymptomatic caliceal calcium nephrolithiasis. J Nephrol. 1996;9:144-6. Google Scholar47. Keeley FX Jr, Tilling K, Elves A, et al. Preliminary results of a randomized controlled trial of prophylactic shock wave lithotripsy for small asymptomatic renal calyceal stones. BJU Int. 2001;87:1-8. [PMID: 11121982] Google Scholar48. Goldfarb DS. Reconsideration of the 1988 NIH Consensus Statement on Prevention and Treatment of Kidney Stones: Are the Recommendations Out of Date? Rev Urol. 2002;4:53-60. [PMID: 16985656] Google Scholar49. Segura JW, Preminger GM, Assimos DG, et al. Nephrolithiasis Clinical Guidelines Panel summary report on the management of staghorn calculi. The American Urological Association Nephrolithiasis Clinical Guidelines Panel. J Urol. 1994;151:1648-51. [PMID: 8189589] Google Scholar50. Preminger GM, Tiselius HG, Assimos DG, et al; American Urological Association Education and Research, Inc. 2007 Guideline for the management of ureteral calculi. Eur Urol. 2007;52:1610-31. [PMID: 18074433] Google Scholar51. Rodman JS, Sosa RE, Seidman C, et al. No More Kidney Stones. Hoboken, NJ: J Wiley; 2007. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byWhat the Radiologist Needs to Know About Urolithiasis: Part 1???Pathogenesis, Types, Assessment, and Variant AnatomyUpdate on the Pathophysiology and Management of Uric Acid Renal Stones 4 August 2009Volume 151, Issue 3Page: ITC2-1KeywordsCalciumComputed axial tomographyDietDrugsExcretionExtracorporeal shock wave lithotripsyKidney stonesSaltsUric acidUrine ePublished: 4 August 2009 Issue Published: 4 August 2009 Copyright & PermissionsCopyright © 2009 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...